Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-03

FDA Approved: NAPROXEN — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved Naproxen from Aurobindo Pharma Limited as an original generic application (ANDA 216504). Naproxen is a nonsteroidal anti-inflammatory drug used to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen (Naproxen)

Snippet

ORIG AP for NAPROXEN (NAPROXEN)